The therapeutic landscape is shifting—and biomarkers are at the center of this transformation. In this exclusive session, we’ll spotlight high-impact protein targets including FOLR1, HER2, Claudin ...

Protein therapeutics play a pivotal role across the modern healthcare landscape, offering treatment options for a wide range of indications. To meet the increased demand for these therapies, it is ...

Consumer health brands face increasing pressure to demonstrate real-world impact, stand out in a crowded market, and adapt quickly to evolving consumer expectations. Traditional evidence-gathering ...

Across the biotech industry, the demand for accelerated time to clinic, operational precision, and robust scalability has never been more critical. Developers face the complexity of solving a growing ...

As the life sciences industry contends with tighter economic conditions and increasing investor scrutiny, integrated innovation partners (IIPs) are emerging as a more effective model than traditional ...

You will receive an email confirmation momentarily. Please reach out to [email protected] with any questions. Use the below links to add this event to your calendar and be sure to check out other ...

Precision medicine is reshaping the landscape of clinical development, offering more advanced strategies to align therapies with individual biological variability. Recent research shows that drug ...

BioInsight plans to connect with population-wide, multimodal studies, including national initiatives and strategic biopharma partnerships.

The New York Stock Exchange helped ring in this year’s Fierce 15 by honoring the winners on the trading floor Monday morning.

As cell and gene therapies, mRNA vaccines, and decentralized trials redefine what’s possible in life sciences, traditional supply chains are under pressure to evolve. Discover how leading ...

Computer-aided drug design (CADD) that combines computational chemistry, molecular modeling, and rational drug design with artificial intelligence (AI) and machine learning is rapidly changing the ...

As cell and gene therapies reshape the oncology landscape, the patient journey is becoming more complex—demanding more than scientific breakthroughs alone. Long-term success hinges on providing ...